<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Weber P</submitter><funding>Austrian Science Fund FWF</funding><pagination>15943-15951</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9029992</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(26)</volume><pubmed_abstract>A set of cyclopentanoid α-galactosidase ligands was prepared from a partially protected ω-eno-aldose &lt;i>via&lt;/i> a reliable (2 + 3)-cycloaddition protocol with slightly modified conditions. The obtained &lt;i>N&lt;/i>-benzylisoxazolidine ring was selectively opened and the configuration of the hydroxymethylgroup was inverted. Consecutive deprotection provided an aminocyclopentane, which was &lt;i>N&lt;/i>-alkylated to furnish a set of potential α-galactosidase inhibitors. Their glycosidase inhibitory activities were screened with a panel of standard glycosidases of biological significance.</pubmed_abstract><journal>RSC advances</journal><pubmed_title>New α-galactosidase-inhibiting aminohydroxycyclopentanes.</pubmed_title><pmcid>PMC9029992</pmcid><funding_grant_id>P 30372</funding_grant_id><pubmed_authors>Wolfsgruber A</pubmed_authors><pubmed_authors>Fischer R</pubmed_authors><pubmed_authors>Nasseri SA</pubmed_authors><pubmed_authors>Withers SG</pubmed_authors><pubmed_authors>Thonhofer M</pubmed_authors><pubmed_authors>Stutz AE</pubmed_authors><pubmed_authors>Weber P</pubmed_authors><pubmed_authors>Wrodnigg TM</pubmed_authors></additional><is_claimable>false</is_claimable><name>New α-galactosidase-inhibiting aminohydroxycyclopentanes.</name><description>A set of cyclopentanoid α-galactosidase ligands was prepared from a partially protected ω-eno-aldose &lt;i>via&lt;/i> a reliable (2 + 3)-cycloaddition protocol with slightly modified conditions. The obtained &lt;i>N&lt;/i>-benzylisoxazolidine ring was selectively opened and the configuration of the hydroxymethylgroup was inverted. Consecutive deprotection provided an aminocyclopentane, which was &lt;i>N&lt;/i>-alkylated to furnish a set of potential α-galactosidase inhibitors. Their glycosidase inhibitory activities were screened with a panel of standard glycosidases of biological significance.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-04-05T11:05:16.717Z</modification><creation>2025-04-05T11:05:16.717Z</creation></dates><accession>S-EPMC9029992</accession><cross_references><pubmed>35481199</pubmed><doi>10.1039/d1ra02507d</doi></cross_references></HashMap>